要抒发反对定见请供给论文数据撑持，不然就是张口就来，不克不及被纳入留言
关键的并不是教给甚么，而要制止教给甚么市道上有一些收集文章，说“闲太多或是太少都难患病”，因而建议少午休，或是别午休。此种讲法源于天然科学研究，但天然科学研究不单没证明午休太长与病症间的两者间，反而倾向于反向指数函数：病症是因，午休久是果。
还有一类讲法，尾盘的困倦是即便胰岛素抵御，假设你身心安康且饮食习惯合理是不克不及困的。此种讲法对想多工做节约天数的人而言似乎很有诱惑力，但却不准确，尾盘的午睡是天然规律，无关于饮食习惯。空点我会弥补确凿证据。
对健身活动者而言，不该受造于“午休天数应该限造在X半小时”那个概念内，需要就多睡。那一方面即便健身活动者有更高的体力恢复需要，另一方面即便每小我所需的午睡原来就有差别。更关键的是，大大都人夜间午睡不敷，午休是他们Tiruvanamalai的关键体例。
总之，就目前确实凿证据而言，并没辨认出午休太长对人体身心安康有甚么危害性。
一、“午休天数长易患病”是对汗青文献的错误阐释确实，有许多确凿证据表白午休天数长与代谢综合症相关：好比几项中国香港的综述[1]，检索了2098篇相关汗青文献，保留了契合前提的10项天然科学研究（四项横切面天然科学研究和六项队列天然科学研究），其次要辨认出是每晚长天数午休超越一半小时与糖尿病流行和爆发信誉风险增加相关。
类似的大型天然科学研究不行那一个，2016年几项基于11万人、包罗9项尝试的元阐发表白夜间午休者糖尿病信誉风险进步19%[2]。只好许多改过闻媒体之类，就起头拿到那些确凿证据给群众宣传：别睡很久，即便睡很久难患病。老苍生总之不克不及去翻汗青文献，只好就信了，还觉得很天然科学，获益匪浅。
但那是对汗青文献的误传，书名做者并并不是抒发闲多就难患病。假设我们认实一些，把汗青文献[1]翻开细细看看，就会辨认出，variations写的是“每晚长天数午休超越一半小时与糖尿病流行和爆发信誉风险增加相关”（associated with：与....相关）。
从天然科学来讲，XX与YY相关，应阐释为XX与YY有相关性，两件事同时发作，但Chavanges，未必具有指数函数。那就比如小华被辨认出呈现在爆炸案辨认出场，至只好并不是他做的，还不晓得，即便完全可能将是其别人预先设置了炸弹。
回到书名，对指数函数，人类学家说的是：夜间长天数午休与2型糖尿病信誉风险间的关系，仍然在很大水平上是不清晰的（largely unkown）。
也就是说，人类学家们都搞不清到底闲久和患病间是并不是有两者间。但天然科学研究人员都搞不清、不敢下结论的事，改过闻媒体却能信誓旦旦的说：就是闲久引致了病症、因而别睡很久——典型的奋不顾身无畏。
二、因果倒转：并不是午休长易患病，而要得了柳巴希夫卡闲久在原汗青文献中，人类学家对午休天数和糖尿病信誉风险的机造，提出了几种可能将按照，但假设我们细细看，那些按照都指向病症是因，闲久是果。
好比，中行吞咽综合症[3]。有此种病症的人，因为睡觉时上吞咽道梗塞（可能将是气管发炎肿胀或瘦削招致），身体高热，被迫唤醒大脑，反频频复屡次从睡梦中醒过来，午睡量量很低，因而夜间异常委靡，嗜睡[18,19,20,21]——也就会招致午休天数太长。
中行吞咽综合症会进一步引起事发作交通变乱[4,5,31]、糖尿病[15,22,23,24,25]、忧郁症[30]、糖尿病、心血管病症[6,7,8,9,10]、发作率进步[11,12,26,27,28,29]。
成果，“午休天数太长”，就被挂上了“引致各类病症/发作率升高”的功名。
Chavanges，越来越多确实凿证据，包罗动物和体外肺癌模子显示，中行吞咽综合症引致的午睡中高热、午睡周期被毁坏，是一类强力的致癌路子[32,33,34,35,36,37,38,39,40]。反过来，假设能十一点多，得肺癌几率下降。我国有些天然科学研究尝试室情况中反频频复论证了生长激素具有必然抗癌的感化，倡导应在肺癌治疗中做为一类辅助体例[41]。
中行吞咽综合症怎么来的？莫非是午休睡多了得的吗？
总之并不是了，在医学上，中行吞咽综合症的次要致病因素是瘦削和慢性炎症[13,14]。各人也不难理解，人太胖难引致炎症，气管塌陷、阻塞[16,17]。
因而前面的元阐发[1]认为，可能将是中行吞咽综合症引致了午睡量量下降，进而引致夜间嗜睡、委靡、午休更久。假设我们做个逻辑梳理：
还有炎症和代谢改动。原做者认为可能将是中行吞咽综合症招致了午睡不敷，从而促进儿茶酚胺/皮量醇升高、炎症因子升高、胰岛素抵御，促成糖尿病。
原做者的揣测是有心理按照的，但是到了某些改过闻媒体那，就全乱了，他们起头起头胡乱解释，说是午休太多引致了上述问题。那显然是缺乏心理学常识的，即便午睡能降低皮量醇、降低炎症因子、进步胰岛敏感性，在心理上确凿证据良多。
好比说：
（1）儿茶酚胺是一根神经传递物量[42]，引起人的兴奋，因而从事理上说，午休不成能将升高儿茶酚胺，只可能将降低。公然，确凿证据表白，午睡不敷才会升高儿茶酚胺[43,44]；
（2）皮量醇：在午睡不敷的尝试室天然科学研究中，午睡褫夺后的晚上皮量醇程度上升[45,46]，持久夜间轮班、做息不规律也会升高皮量醇[47]；
（3）炎症：午睡障碍或失眠[48]、中行吞咽综合症患者[49,50]会升高炎症标识表记标帜物程度。对炎症标识表记标帜物（C卵白）的天然科学研究辨认出，假设对午睡中行吞咽停止治疗，午十一点多转，则C卵白程度下降[51]；
（4）胰岛素抵御：Bescos等人f辨认身世心安康成人仅需4天的模仿夜班工做就足以降低胰岛素敏感性25%摆布，增加他们患糖尿病的信誉风险——同时那也引致了他们的骨骼肌摄取的葡萄糖削减；
Orfeu等人的天然科学研究辨认出，20名身心安康年轻人仅仅持续5晚只睡5半小时，他们的胰岛敏感性均匀下降了20%摆布[52]；
午睡不敷、日夜节律失调会影响动物的碳水化合物的代谢[53]，引致动物的葡萄糖代谢改动：小鼠发作高血糖、瘦削和代谢综合症等[54]；
对美国人的天然科学研究数据显示，午睡不敷，而非午睡过度，与瘦削[55,56,57,58,59]、糖尿病[59,60,61,62,63]间存在联系关系。
三、长/短午睡固然都升高糖尿病信誉风险，但在素质上完全差别良多人都传闻过“不要闲很久，睡很久难患病”的讲法。略微看过一些材料的人还晓得午睡天数与病症信誉风险间，存在U型关系。
好比2014年的几项中国的元阐发，汇总了11项天然科学研究，此中包罗了48.2万人和1.8万名糖尿病患者[64]，该天然科学研究的结论是每晚睡7-8半小时的人患糖尿病的信誉风险更低。
也就是说，闲少和闲多的人，糖尿病几率城市升高，只要睡中间长度（7-8半小时）的人，几率更低。因而整合出来就是个U型关系。
如许的数据并不是个例，是常见规律。别的几项元阐发[65]，纳入了10项天然科学研究和107756名受试者，辨认出午睡太短午睡（夜间＜5~6 半小时）与2型糖尿病信誉风险升高28%相关；午睡太长（夜间>8~9半小时）与2型糖尿病信誉风险升高48%相关。
因而呢？闲多和闲少就都有害了吗？
总之并不是。就目前确实凿证据汇总看，闲少和闲多固然都升高病症信誉风险，但在性量上差别。闲少与病症间，存在明白的两者间，我之前写过，确凿证据堆积如山，机造也十分明晰。
为何一天1半小时的力量+高强度无氧+1半小时有氧跑，已对峙近半个月既没减脂又没增肌？
但闲多与病症信誉风险升高，就目前确实凿证据看，次要是反向两者间。除了我们在之前说的中行吞咽综合（及其引发的内排泄、炎症程度变革、胰岛抵御）外，还有有其他机造。
好比炎症。糖尿病与瘦削和高热量饮食习惯关系亲近，而脂肪组织不但贮存能量，也是内排泄器官[86]，脂肪组织通过巨噬细胞来释放炎症因子，因而糖尿病人往往慢性炎症程度升高[74]。
典型的炎症因子如肿瘤坏死因子TNF-α[87,88]、白介素IL[89]等。它们做为午睡调理物量，在NREM午睡中的感化得到了动物尝试的证明[75,84]。
假设利用拮抗剂（如白介素-1受体拮抗剂）可导动物NREM午睡量削减；反过来，加强炎症因子会促进NREM的午睡量和强度，那证大白介素1和肿瘤坏死因子TNF都能调理午睡[85,90]。
好比起夜。超越50%的糖尿病人午睡量量欠好[69,70,71]，即便糖尿病人的血糖控造欠好[73]，夜间频繁起夜小便[72]，将午睡天数割裂为多个小碎片，无法进入深度午睡周期，引致午睡量量下降，从而需要更多的午睡长度来填补。
还有其他可能将。Francesco等人对包罗138.3万人的16项天然科学研究停止了荟萃阐发[76]。其成果是短午睡增加灭亡信誉风险12%，长午睡增加30%。咱间接看看原做者的解释：
短午睡与病症间的机造，包罗促进食欲的激素增加、按捺食欲的激素削减，促进瘦削和糖耐受受损，增加心血管病症信誉风险、增加皮量醇的排泄。午睡不敷引发轻度炎症，那不只可能将引致心血管病症，也可能将引致其他慢性病症，包罗肺癌。
相反，到目前为行，还没有颁发的天然科学研究证明长天数午睡可引致病症率进步和慢性病症。长午睡与发作率间的关系可能将是混淆因素引起的，好比忧郁症、社会地位和经济程度低、赋闲、低体力活动程度、身心安康不良、肺癌引致的委靡等。
其它大型天然科学研究也撑持Francesco等人的概念。Xiang等人的天然科学研究查询拜访了查询拜访了60,586名40岁或40岁以上的成年人，辨认出午睡天数短与冠心病的信誉风险间的相关性具有统计学意义，但午睡天数长（≥8半小时）与心血管病症信誉风险间的关系不具有统计学意义[65]。
由此可见，几乎全数的人类学家都找不到午睡太长危险身心安康确实凿证据，都认为是有了其他病症才引致午睡太长的，也就是说，长午睡是无辜的。
四、耽误午睡能否有利于身心安康？固然从外表上看，长午睡与病症信誉风险升高联络在一路，但是仅仅“联络在一路”，其实不能证明耽误午睡到底是损害了仍是促进了身心安康。
用前面举过的小华和爆炸案的例子而言，我们其实不能即便他呈现在案辨认出场，就说他必然是功犯。反过来，他还可能将是去阻遏爆炸的。
因而，关键仍是机造。
对16名身心安康意愿者停止的天然科学研究显示，6周的夜间午睡天数耽误了1半小时，固然空腹血糖和胰岛素程度没有改善，但胰岛敏感性有所增加[66]。
书名结论是：午睡不敷的人午睡耽误超越6周对胰岛素敏感性有有利的影响。
还有几项对125名瘦削者停止的午睡耽误的随机试验辨认出，与对照组比拟，耽误午睡30分钟，对血压和胰岛敏感性有有利影响[69]，空腹血糖下降8%，空腹胰岛素下降26%。
此外，几项为期4周的小范畴随机天然科学研究辨认出，午睡耽误组和对照组在空腹血糖、胰岛素方面没有差别，不外那是即便他们上床早，但现实上入睡的天数没有明显增加[68]。
五、反对限造午休天数，从身心安康而言应该想睡多久睡多久次要有3个原因。
第一个原因：每小我应该健身活动/运动，不然人的身体就是不一般的，罕见肺癌和各类病。
久坐危害性有多大？
若何对待我国老年人健身活动很少停止力量训练，而要采纳快走等有氧耐力运动？
为甚么总有人把健身活动等同于“增肌”？
运动和健身活动都需要更多的午睡来恢复体力/精神，修复身体，因而应该允许充沛的午睡，包罗午休。
第二个原因：每小我原来就存在个别基因差别，有些人就需要较长的午睡天数。即便人类至少几千个基因影响午睡，仅仅关系到骨骼肌自己日夜节律的基因，就有2300多个。
人类学家从上世纪30年代起就通过双胞胎天然科学研究辨认出午睡长度是可遗传的[78，79]，午睡天数的遗传率约为10-21%，此中涉及多个时钟基因。
一个对美国度庭的天然科学研究辨认出，此中有2个成员每晚只需要水6半小时，其他成员需要睡8半小时；那是因为那2人的hDEC2-P385R基因发作了突变（C-G突变）。
有两项目较大的天然科学研究，别离搜集了4.7万人和44.6万人的数据，辨认出人类有多个基因位点与午睡天数相关[80,81]：生长激素受体基因rs-4753426，它的多态性影响了与周末睡觉的天数；另一类基因变体rs-7942988，也已被证明会影响生长激素排泄的持续天数[82,83]。
对那些需求午睡较多的人，非要他人午休短一些，就明显不合理。
第三个原因：午睡不敷 等人越来越多。各人端赖午休来“Tiruvanamalai”。
某些收集文章，错误阐释汗青文献，做出机械死板的教条式建议，提出要“少午休、不午休”，轻忽广阔知友遍及午睡不敷的问题，完全不接地气，许多人都觉得受不了。
此种留言是良多人的心声。
总而言之，能睡多久睡多久，目前还没有明白的天然科学确凿证据证明午休天数长了有害。
反过来，各人实正应该思虑的问题是，假设如那些收集文章所说，要求那些即便病症而耽误了午休天数的人强迫削减午休天数，他们会如何？
那个问题能够留到留言板切磋。
本文完毕，感激阅读。
扩展阅读有哪些是你健身活动久了晓得的事？
References1. Vivian Yawei Guo 1 , Bing Cao 2 , Carlos King Ho Wong 3 , Esther Yee Tak Yu 3.The association between daytime napping and risk of diabetes: a systematic review and meta-analysis of observational studies.Sleep Med. 2017 Sep;37:105-112.
2. Wisit Cheungpasitporn 1 , Charat Thongprayoon 1 , Narat Srivali 2 , Priya Vijayvargiya 3 , Carl A Andersen 3 , Wonngarm Kittanamongkolchai 1 , Insara J Jaffer Sathick 1 , Sean M Caples 2 , Stephen B Erickson 1.The effects of napping on the risk of hypertension: a systematic review and meta-analysis.J Evid Based Med. 2016 Nov;9(4):205-212.
3. Masa JF, Rubio M, Perez P, Mota M, de Cos JS, Montserrat JM. Association between habitual naps and sleep apnea. Sleep. 2006;29:1463-8. 4. Masa JF, Rubio M, Findley LJ and Cooperative Group. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 2000;162:1407-12.
5. Terán J, Jiménez A, Cordero J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999;340:847-51.
6. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
7. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large communitybased study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
8. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001;163:685-9.
9. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:375-80.
10. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-4.
11. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LH, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
12. Marin JM, Carrizo SJ, Vivente E, Agusti A. Long-term cardiovascular outcomes in men with obstructive sleep apnoea- hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-53.
13. Araghi MH, Chen YF, Jagielski A, et al. Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep. 2013;36(10):1553–1562.
14. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–542.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
16. Dear KBG, Begg CB. An approach for assessing publication bias prior to performing a meta-analysis. Statistical Science. 1992;7:237–45.
17. R Development Core Team. Vienna, Austria: R Foundation for Statistical Computing; 2012. R: A Language and Environment for Statistical Computing.
18. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001;134(11):1015–1023.
19. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999;353(9170):2100–2105.
20. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med. 1998;157(3 Pt 1):858–865.
21. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307(20):2161–2168.
22. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001;134(11):1015–1023.
23. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107(1):68–73.
24. Duran-Cantolla J, Aizpuru F, Montserrat JM, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010;341:c5991.
25. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–2415.
26. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307(20):2161–2168. [PubMed] [Google Scholar]
27. Parra O, Sanchez-Armengol A, Capote F, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res. 2015;24(1):47–53. [PubMed] [Google Scholar]
28. Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunstrom E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with non-sleepy obstructive sleep apnea: the RICCADSA randomized controlled trial. Am J Respir Crit Care Med. 2016;194(5):613–620.
29. Barbe F, Sunyer J, de la Pena A, et al. Effect of continuous positive airway pressure on the risk of road accidents in sleep apnea patients. Respiration. 2007;74(1):44–49.
30. Acker J, Richter K, Piehl A, Herold J, Ficker J, Niklewski G. Obstructive sleep apnea (OSA) and clinical depression—prevalence in a sleep center. Sleep and Breathing. 2016:1–8.
31. Barger LK, Rajaratnam S, Wang W, OBrien CS, Sullivan JP, Quadri S. Common sleep disorders increase risk of motor vehicle crashes and adverse health outcomes in firefighters. J Clin Sleep Med. 2015;11(3):233–240.
32. Almendros I, Montserrat JM, Torres M, et al. Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Respiratory physiology & neurobiology. 2013;186(3):303–307.
33. Khalyfa A, Almendros I, Gileles-Hillel A, et al. Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation. Oncotarget. 2016.
34. Zheng J, Almendros I, Wang Y, et al. Reduced NADPH oxidase type 2 activity mediates sleep fragmentation-induced effects on TC1 tumors in mice. OncoImmunology. 2015;4(2):e976057.
35. Gozal D, Farré R, Nieto FJ. Putative links between sleep apnea and cancer: From hypotheses to evolving evidence. CHEST Journal. 2015;148(5):1140–1147.
36. Hakim F, Wang Y, Zhang SX, et al. Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. Cancer Res. 2014;74(5):1329–1337. doi: 10.1158/0008-5472.CAN-13-3014
37. Nanduri J, Prabhakar NR. Intermittent hypoxia: Mechanistic pathways influencing cancer In: Impact of sleep and sleep disturbances on obesity and cancer. Springer; 2014:103–119.
38. Miao Z, Zhao T, Wang Z, et al. Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells. Tumor Biol. 2014;35(7):6801–6808.
39. Zhang J, Guo X, Shi Y, Ma J, Wang G. Intermittent hypoxia with or without hypercapnia is associated with tumorigenesis by decreasing the expression of brain derived neurotrophic factor and miR-34a in rats. Chin Med J (Engl). 2014;127(1):43–47.
40. Almendros I, Montserrat JM, Ramirez J, et al. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur Respir J. 2012;39(1):215–217.
41. Ye-min Wang. Bao-zhe Jin. Fang Ai. Chang-hong Duan. Yi-zhong Lu. Ting-fang Dong. Qing-lin Fu.The eYcacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.
42. Graeme Eisenhofer 1 , Irwin J Kopin, David S Goldstein.Catecholamine metabolism: a contemporary view with implications for physiology and medicine.Pharmacol Rev. 2004 Sep;56(3):331-49.
43. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303–7.
44. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab. 1999;84(6):1979–85.
45. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20(10):865–70.
46. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–9.
47. Manenschijn L, van Kruysbergen RG, de Jong FH, Koper JW, van Rossum EF. Shift work at young age is associated with elevated long-term cortisol levels and body mass index. J Clin Endocrinol Metab.
48. Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016;80(1):40–52.
49. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2006;174(7):824–30.
50. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107(8):1129–34.
51. Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370(24):2276–85.
52. Orfeu M. Buxton,1,2 Milena Pavlova,2,3 Emily W. Reid,1 Wei Wang,1,2 Donald C. Simonson,1,2 and Gail K. Adler1,2.Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men.Diabetes. 2010 Sep; 59(9): 2126–2133.
53. Rey G., Cesbron F., Rougemont J., Reinke H., Brunner M., Naef F. Genome-wide and phase-specific DNA-binding rhythms of BMAL1 control circadian output functions in mouse liver.PLoS Biology.2011;9:e1000595
54. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E. Obesity and metabolic syndrome in circadian Clock mutant mice.Science.2005;308:1043–1045.
55. Cizza G, Skarulis M, Mignot E. A link between short sleep and obesity: building the evidence for causation. Sleep 2005;28:1217–1220.
56. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289–1296.
57. Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, Rossler W, Angst J. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 2004;27:661–666
58. Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 2005;165:25–30.
59. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003;26:380–384
60. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007;30:1667–1673.
61. Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863–867.
62. Meisinger C, Heier M, Loewel H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005;48:235–241.
63. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006;29:657–661
64. Shan Z, Ma H, Xie M, Yan P, Guo Y, Bao W et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529–37.
65. Cappuccio FP, DElia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414–20.
66. Bakker JP, Weng J, Wang R, Redline S, Punjabi NM, Patel SR. Associations between Obstructive Sleep Apnea, Sleep Duration, and Abnormal Fasting Glucose. The Multi-Ethnic Study of Atherosclerosis. Am J Respir Crit Care Med. 2015;192(6):745–53.
67. Leproult R, Deliens G, Gilson M, Peigneux P. Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction. Sleep. 2015;38(5):707–15.
68. Al Khatib HK, Hall WL, Creedon A, Ooi E, Masri T, McGowan L et al. Sleep extension is a feasible lifestyle intervention in free-living adults who are habitually short sleepers: a potential strategy for decreasing intake of free sugars? A randomized controlled pilot study. The American journal of clinical nutrition. 2018;107(1):43–53.
69. Luyster F.S., Dunbar-Jacob J. Sleep Quality and Quality of Life in Adults with Type 2 Diabetes. Diabetes Educ. 2011;37:347–355.
70. Ramtahal R., Khan C., Maharaj-Khan K., Nallamothu S., Hinds A., Dhanoo A., Yeh H.-C., Hill-Briggs F., Lazo M. Prevalence of self-reported sleep duration and sleep habits in type 2 diabetes patients in South Trinidad. J. Epidemiol. Glob. Health. 2015;5(Suppl. 1):S35–S43.
71. Jemere T., Mossie A., Berhanu H., Yeshaw Y. Poor sleep quality and its predictors among type 2 diabetes mellitus patients attending Jimma University Medical Center, Jimma, Ethiopia. BMC Res. Notes. 2019;12:488.
72. Hashimoto Y., Sakai R., Ikeda K., Fukui M. Association between sleep disorder and quality of life in patients with type 2 diabetes: A cross-sectional study. BMC Endocr. Disord. 2020;20:98.
73. Cunha M.C., Zanetti M.L., Hass V.J. Sleep quality in type 2 diabetics. Rev. Lat. Am. Enfermagem. 2008;16:850–855.
74. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (1985). 2009;106(5):1538–44.
75. Michael R. Irwin,1,2,3 Richard Olmstead,1,2 and Judith E. Carroll1,2.Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation.Biol Psychiatry. Author manuscript; available in PMC 2017 Jul 1.
76. Francesco P. Cappuccio, MD, FRCP1 ; Lanfranco D’Elia, MD2 ; Pasquale Strazzullo, MD2 ; Michelle A. Miller, PhD1. Sleep Duration and All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies. SLEEP, Vol. 33, No. 5, 2010
77. Hirshkowitz M, et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Heal. 2015;1:40–43.
78. Partinen M, Kaprio J, Koskenvuo M, Putkonen P, Langinvainio H. Genetic and environmental determination of human sleep. Sleep. 1983;6:179–85.
79. Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev. 2005;9:91–100.
80. Dashti HS, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10:1100.
81. Gottlieb DJ, et al. Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study. Mol Psychiatry. 2015;20:1232–9.
82. Silva ACPe, et al. Melatonin receptor 1B ?1193T>C polymorphism is associated with diurnal preference and sleep habits. Sleep Med. 2019;53:106–14.
83. Chang A-M, et al. Circadian gene variants influence sleep and the sleep electroencephalogram in humans. Chronobiol Int. 2016;33:561–73.
84. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–14.
85. Nguyen KT, Korner J. The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr Diab Rep. 2014;14:481.
86. Sandra Galic 1 , Jon S Oakhill, Gregory R Steinberg.Adipose tissue as an endocrine organ.Mol Cell Endocrinol. 2010 Mar 25;316(2):129-39.
87. Shimomura I., Funahashi T., Matsuzawa Y. Significance of adipocytokine, fat-derived hormones, in metabolic syndrome. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme. 2002;47(14):1896–1903.
88. Adamska A., Nikołajuk A., Karczewska-Kupczewska M., et al. Relationships between serum adiponectin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjects. Acta Diabetologica. 2012;49(1):17–24.
89. Salmenniemi U., Zacharova J., Ruotsalainen E., et al. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism. 2005;90(7):4216–4223.